Fisher Healthcare™ Sure-Vue™ RPR Antigen Suspension

Description

Sure-Vue’s non-treponemal RPR antigen screens for syphilis; a sexually transmitted disease caused by the bacterium Treponema pallidum (a spirochete bacteria). The disease is found worldwide and is easily treated if detected early. This test is FDA cleared for use in diagnostic screening.

• CLIA Complexity: Non-Waived
• CPT Codes: 86542/86593
• Cardiolipin charcoal microparticle test for the qualitative and semi-quantitative determination of reagin, which is associated with syphilis
• Antigen detects 'reagin' present in serum of syphilitic patients
• Test results in eight minutes
• Positive results yield a flocculation of the antigen; negative results yield no reaction and a gray homogeneous suspension, or a button of non-aggregating carbon particles in the center of the circle
• For in vitro diagnostic use
• Contains Sodium Azide 0.1%

Specifications

• Description: RPR Antigen Suspension
• CE Marker: Self-declared
• Clia Complexity: Moderate (Serum, Plasma or Whole Blood), Waived (Other)
• Detectable Analytes: Reagin (Syphilis)
• Type: RPR Antigen Suspension
• Disposable: Single-use
• For Use With (Application): For in-vitro diagnostic use
• Quantity: 1 x 9 mL
• Form: Ready-to-Use (RTU)